vs
Side-by-side financial comparison of COMERICA INC (CMA) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $838.0M, roughly 1.7× COMERICA INC). COMERICA INC runs the higher net margin — 21.0% vs 4.5%, a 16.5% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (5.0% vs 3.3%). Over the past eight quarters, COMERICA INC's revenue compounded faster (108.9% CAGR vs 5.3%).
Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
CMA vs SEM — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $838.0M | $1.4B |
| Net Profit | $176.0M | $63.8M |
| Gross Margin | — | — |
| Operating Margin | — | 6.9% |
| Net Margin | 21.0% | 4.5% |
| Revenue YoY | 3.3% | 5.0% |
| Net Profit YoY | -4.3% | -14.7% |
| EPS (diluted) | $1.35 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $838.0M | $1.4B | ||
| Q2 25 | $849.0M | $1.3B | ||
| Q1 25 | $829.0M | $1.4B | ||
| Q4 24 | $825.0M | $1.3B | ||
| Q3 24 | $811.0M | $1.3B | ||
| Q2 24 | $824.0M | $1.3B |
| Q1 26 | — | $63.8M | ||
| Q4 25 | — | $20.2M | ||
| Q3 25 | $176.0M | $28.8M | ||
| Q2 25 | $199.0M | $40.6M | ||
| Q1 25 | $172.0M | $56.7M | ||
| Q4 24 | $170.0M | $-16.1M | ||
| Q3 24 | $184.0M | $55.6M | ||
| Q2 24 | $206.0M | $77.6M |
| Q1 26 | — | 6.9% | ||
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | — | 5.8% |
| Q1 26 | — | 4.5% | ||
| Q4 25 | — | 1.4% | ||
| Q3 25 | 21.0% | 2.1% | ||
| Q2 25 | 23.4% | 3.0% | ||
| Q1 25 | 20.7% | 4.2% | ||
| Q4 24 | 20.6% | -1.2% | ||
| Q3 24 | 22.7% | 4.4% | ||
| Q2 24 | 25.0% | 6.1% |
| Q1 26 | — | $0.35 | ||
| Q4 25 | — | $0.17 | ||
| Q3 25 | $1.35 | $0.23 | ||
| Q2 25 | $1.42 | $0.32 | ||
| Q1 25 | $1.25 | $0.44 | ||
| Q4 24 | $1.22 | $-0.12 | ||
| Q3 24 | $1.33 | $0.43 | ||
| Q2 24 | $1.49 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $25.7M |
| Total DebtLower is stronger | $5.4B | $1.8B |
| Stockholders' EquityBook value | $7.4B | $2.1B |
| Total Assets | $77.4B | $6.0B |
| Debt / EquityLower = less leverage | 0.73× | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $25.7M | ||
| Q4 25 | — | $26.5M | ||
| Q3 25 | — | $60.1M | ||
| Q2 25 | — | $52.3M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | — | $59.7M | ||
| Q3 24 | — | $191.5M | ||
| Q2 24 | — | $111.2M |
| Q1 26 | — | $1.8B | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | $5.4B | $1.7B | ||
| Q2 25 | $5.8B | $1.8B | ||
| Q1 25 | $5.7B | $1.8B | ||
| Q4 24 | $6.7B | $1.7B | ||
| Q3 24 | $6.8B | $3.1B | ||
| Q2 24 | $7.1B | $3.6B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | — | $1.7B | ||
| Q3 25 | $7.4B | $1.7B | ||
| Q2 25 | $6.9B | $1.7B | ||
| Q1 25 | $7.1B | $1.7B | ||
| Q4 24 | $6.5B | $1.7B | ||
| Q3 24 | $7.4B | $1.9B | ||
| Q2 24 | $6.2B | $1.4B |
| Q1 26 | — | $6.0B | ||
| Q4 25 | — | $5.9B | ||
| Q3 25 | $77.4B | $5.7B | ||
| Q2 25 | $78.0B | $5.7B | ||
| Q1 25 | $77.6B | $5.7B | ||
| Q4 24 | $79.3B | $5.6B | ||
| Q3 24 | $79.7B | $8.0B | ||
| Q2 24 | $79.6B | $7.9B |
| Q1 26 | — | 0.88× | ||
| Q4 25 | — | 1.06× | ||
| Q3 25 | 0.73× | 1.03× | ||
| Q2 25 | 0.84× | 1.10× | ||
| Q1 25 | 0.81× | 1.03× | ||
| Q4 24 | 1.02× | 1.01× | ||
| Q3 24 | 0.92× | 1.62× | ||
| Q2 24 | 1.15× | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-270.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -1.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $64.3M | ||
| Q3 25 | $-270.0M | $175.3M | ||
| Q2 25 | $476.0M | $110.3M | ||
| Q1 25 | $273.0M | $-3.5M | ||
| Q4 24 | $601.0M | $125.4M | ||
| Q3 24 | $1.0B | $181.0M | ||
| Q2 24 | $111.0M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.2M | ||
| Q3 25 | — | $122.2M | ||
| Q2 25 | — | $45.6M | ||
| Q1 25 | — | $-55.8M | ||
| Q4 24 | — | $62.0M | ||
| Q3 24 | — | $130.3M | ||
| Q2 24 | — | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 9.0% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | -4.1% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.19× | ||
| Q3 25 | -1.53× | 6.09× | ||
| Q2 25 | 2.39× | 2.72× | ||
| Q1 25 | 1.59× | -0.06× | ||
| Q4 24 | 3.54× | — | ||
| Q3 24 | 5.70× | 3.25× | ||
| Q2 24 | 0.54× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
